Pharmacovigilance Asia 2014

Complying with Regulations, Reviewing RMPs for Asia, and Improving Audits and ADR Reporting.

25-27 Nov 2014 at Iqpc Worldwide Pte Ltd, Singapore, Singapore

Medical & Health Care, Pharmaceuticals/Drug Discovery

Pharmacovigilance Asia 2014 25-27 Nov 2014 Iqpc Worldwide Pte Ltd, Singapore, Singapore
Submit new post
Thank you for posting.
Share it:
More

Speakers ({{speakersCount}})

Show all

People (1)

Show all

Today pharmacovigilance is on the minds of every pharma and bio executive, and starts earlier in the drug development process. And rightly so, considering the startling fact that 200,000 patients die each year from Adverse Drug Reactions. Pharma/Biotech companies are faced with the challenge of finding solutions that can improve the quality and analysis of safety data, while managing the increase in the quantity of data and the need to satisfy regulatory requirements.

It is this developing threat environment and the challenges facing pharmacovigilance professionals that the 5th Annual Pharmacovigilance Asia Summit 25th-27th November will be addressing.

Join your peers at Pharmacovigilance Asia 2014 to learn how to:
1. Comply with multiple regulations: Significant recent and impending regulatory changes in Asia and EMA
2. Develop risk management plans for Asia
3. Improve your Quality management systems for PV 4
4. Comply with the latest regulatory standards for audits/inspections
5. Author PBRERs as against PSURs
6. Review PSMF structure and Medical Review of ICSRs

URLs:

Inquiries: http://atnd.it/13371-1

Price:
Standard: SGD 3299
Conference + 1 Workshop: SGD 4448
Conference + 2 Workshops: SGD 5597
Conference + 3 Workshops: SGD 6746

When
From: November 25, 2014 09:00
To: November 27, 2014 17:00
Where

Iqpc Worldwide Pte Ltd, 1 Robinson Rd, 068893, Singapore, Singapore

Category

Medical & Health Care, Pharmaceuticals/Drug Discovery

Contact email
laurann.deverteuil@iqpc.com.sg

Contact phone
+65 67229388

External link

Submitted by:

evvnt Platform

Are you the organizer?

Get in touch